Tweet Archive for hashtag “#ASCO16” « page 2
#ASCO16 news about metastatic #melanoma #skincancer
Examining the role of combination #immunotherapy treatment for patients w/ metastatic melanoma https://t.co/K4HkHD8tEj #ASCO16
— ASCO (@ASCO) June 4, 2016
RT @PoschChristian: ASCO – the Woodstock of oncology. #ASCO16 #cancer #melanoma #pd1 pic.twitter.com/dYtLBKDn0h
About #asco16 Educational Book. Among others #melanoma #skincancer
Over 250 oncologists and researchers contributed to the #ASCO16 Educational Book. Have you read it yet? https://t.co/aKanDBqqsc
— ASCO (@ASCO) June 5, 2016
RT @NatureMedicine: Several companies are now looking at neoantigen vaccines as #cancer treatment: rdcu.be/iGNu #ASCO16 https://…
RT @wtspres: Helpful pictures but doesn’t replace experienced dermatologist #asco16 #skincancer #melanoma
Online Tool Helps Users Distinguish Moles from #Melanoma https://t.co/UqVfGiszEM @NCIEpiTraining #SkinCancer #ASCO16 pic.twitter.com/jv8KI4ktd7
— National Cancer Inst (@theNCI) June 4, 2016
Eventual cancer “cure” #skincancer #asco16
Promising drugs stoke talk of eventual cancer 'cure' https://t.co/hPzcZboHTl
— Reuters Health (@Reuters_Health) June 3, 2016
#ASCO16 and #skincancer #cancerawareness
Skin cancer: pembrolizumab gives '40% melanoma survival' #ImmunoOnc #ASCO16 https://t.co/Z1B6F4wfB8
— Miguel Perales M.D. (@DrMiguelPerales) May 19, 2016
#ASCO16 and #skincancer #cancerawareness
Read the #Keytruda #pembrolizumab #ASCO16 results now on #medipaper #ImmuneCheckPoint #melanoma #nsclc #skincancerhttps://t.co/zvU3tthBPP
— MEDIPAPER | 醫學作家香港 (@MediPaper) May 20, 2016
#ASCO16 and #skincancer #cancerawareness
#Keytruda having impressive data at #ASCO16 in #Melanoma. Data here: https://t.co/KtaC1Fhubh#skincancer #asco2016
— MEDIPAPER | 醫學作家香港 (@MediPaper) May 20, 2016
#ASCO16 and #skincancer #cancerawareness
Merck and Pfizer will be sharing new data in #MerkelCellCarcinoma on June 6 at #ASCO16 #AdvanceIO #SkinCancer
— Merck (@merckgroup) May 30, 2016